“Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand”, PLoS One, vol. 10, no. 5, p. e0127998, 2015.,
“Risk Behaviour and Time as Covariates for Efficacy of the HIV Vaccine Regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A Post-Hoc Analysis of the Thai Phase 3 Efficacy Trial RV 144”, Lancet Inf Dis, vol. 12, pp. 531-537, 2012.,
“Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand”, PLoS One, vol. 6, p. e27837, 2011.
“Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand”, N Engl J Med, vol. 361, pp. 2209-2220, 2009.,